Is antiretroviral therapy adherence substantially worse on weekends than weekdays?

Journal of Acquired Immune Deficiency Syndromes

Volumn 54, Issue 1, 2010, Pages 109-110

  Bachhuber, Marcus ^a   Bilker, Warren B ^a   Wang, Hao ^a   Chapman, Jennifer ^a   Gross, Robert ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAILY LIFE ACTIVITY; EMPLOYMENT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK ASSESSMENT;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; TIME FACTORS;

EID: 77951695245     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3181cbd34b     Document Type: Letter

References (13)

1. Gross R, Bilker WB, Friedman HM, et al. Effect of adherence to newly initiated antire-troviral therapy on plasma viral load. AIDS. 2001;15:2109-2117.
2. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Inten Med. 2000;133:21-30.
3. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
4. Cook RL, Sereika SM, Hunt SC, et al. Problem drinking and medication adherence among persons with HIV infection. J Gen Intern Med. 2001;16:83-88.
5. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002; 17:377-381.
6. Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr. 2001;28:445-449.
7. Chesney MA. Factors affecting adherence to antiretroviral therapy. Clin Inf Dis. 2000; 30(Suppl 2):S171-S176.
8. Graham J, Bennett IM, Holmes WC, et al. Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS Behav. 2007; 11:385-392.
9. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S136-S139. (Pubitemid 35453574)
10. Gross R, Bilker WB, Wang H, et al. How long is the window of opportunity between adherence failure and virologic failure on efavirenz-based HAART? HIV Clin Trials. 2008;9:202-206.
11. Kruse W, Rampmaier J, Ullrich G, et al. Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther. 1994;32:452-457.
12. Carroll CL, Feldman SR, Camacho FT, et al. Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004;51:212-216.
13. Leserman J, Ironson G, O'Cleirigh C, et al. Stressful life events and adherence in HIV. AIDS Patient Care STDS. 2008;22:403-411.